These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 176399)

  • 1. Immune reactivity in the Moloney strain of murine sarcoma virus oncogenesis: requirement of thymus-derived lymphocytes for in vivo protection.
    Collavo D; Colombatti A; Biasi G; Chieco-Bianchi L; Davies AJ
    J Natl Cancer Inst; 1976 Mar; 56(3):603-8. PubMed ID: 176399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of M-MuSV tumour regression associated with T lymphocyte tolerance.
    Chieco-Bianchi L; Collavo D; Zanovell P; De Rossi A; Davies AJ
    Nature; 1980 Jun; 285(5767):667-8. PubMed ID: 6248790
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
    Kirchner H; Chused TM; Herberman RB; Holden HT; Lavrin DH
    J Exp Med; 1974 Jun; 139(6):1473-87. PubMed ID: 4598016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-T-cell-mediated cytotoxicity in mice with tumors induced by Moloney murine sarcoma virus (M-MuSV). II. Granulocyte-mediatd cytotoxicity against autochthonous target cells isolated from M-MuSV-induced tumors.
    Becker S; Haskill S
    J Natl Cancer Inst; 1980 Aug; 65(2):469-75. PubMed ID: 6249952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological study of two stocks of Moloney sarcoma virus producing regressor and progressor tumors in C57BL/6 mice.
    Takeichi N; Boone CW; Holden HT; Herberman RB
    Int J Cancer; 1978 Jan; 21(1):78-84. PubMed ID: 203543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of in vitro growth of lymphoma cells by macrophages from tumor-bearing mice.
    Kirchner H; Holden HT; Herberman RB
    J Natl Cancer Inst; 1975 Oct; 55(4):971-5. PubMed ID: 171434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult murine lymph node cells respond blastogenically to a new differentiation antigen on isologous and autologous B lymphocytes.
    Ponzio NM; Finke JH; Battisto JR
    J Immunol; 1975 Mar; 114(3):971-5. PubMed ID: 122992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal IgM antibodies that inhibit primary Moloney murine sarcoma growth.
    Lamon EW; Powell TJ; Walia AS; Lidin BI; Srinivas RV; Baskin JG; Kearney JF
    J Natl Cancer Inst; 1987 Mar; 78(3):547-56. PubMed ID: 3469466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonizing capacity of lymphoid cells injected into syngeneic hosts.
    Kastelan A; Springer O; Bunarević A
    Adv Exp Med Biol; 1973; 29(0):43-8. PubMed ID: 4604242
    [No Abstract]   [Full Text] [Related]  

  • 12. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
    J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymosin, a thymic hormone influencing lymphoid cell immunological competence.
    White A; Goldstein AL
    Ciba Found Study Group; 1970; 36():3-23. PubMed ID: 4399435
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytostasis of lymphoma cells in suspension: probable non-thymic origin of the cytostatic lymphoid cells in mice bearing mys -induced tumors.
    Senik A; de Giorgi L; Gomard E; Levy JP
    Int J Cancer; 1974 Sep; 14(3):396-400. PubMed ID: 4376521
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor inhibiting capacity of spleen and lymph node cells from mice with murine sarcoma virus (MSV-M)-induced tumors.
    Weiland E; Mussgay M
    Z Immunitatsforsch Exp Klin Immunol; 1975 Nov; 150(5):414-23. PubMed ID: 181922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of thymectomy on tumor development and on T and B lymphocytes in tumor-bearing rats.
    Klobusická M; Koníková E; Novotná L
    Neoplasma; 1979; 26(4):413-21. PubMed ID: 392324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STUDIES ON IMMUNOLOGIC RECONSTITUTION OF THYMECTOMIZED MICE.
    YUNIS EJ; HILGARD HR; MARTINEZ C; GOOD RA
    J Exp Med; 1965 Apr; 121(4):607-32. PubMed ID: 14276780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation of donor marrow and thymus cells in the myeloid and lymphoid organs of irradiated syngeneic host mice.
    Takada A; Takada Y
    J Exp Med; 1973 Feb; 137(2):543-6. PubMed ID: 4539849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulatory effect of immunization on tumor induction by Moloney murine sarcoma virus.
    Murasko DM; Prehn RT
    J Natl Cancer Inst; 1978 Nov; 61(5):1323-7. PubMed ID: 213613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.